Diabetic Foot Ulcer Treatment Market Share

North American Market Forecast   

The North American diabetic foot ulcer treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.

APAC Market Statistics

The Asia Pacific diabetic foot ulcer treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The market growth in the region is expected on the account of a rise in the number of patients suffering from diabetes. According to the World Health Organization around 77 million Indians over the age of 18 have type 2 diabetes, and over 25 million are prediabetics More than 50% of people do not know they have diabetes, which can cause serious health problems if not diagnosed timely and not provided with adequate treatment. Moreover, this number of further expected to reach around 135 million by 2045.